A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine Joshua T. AyersRui XuPeter A. Crooks OriginalPaper Article: 75
Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters Christopher K. SurrattOkechukwu T. UkairoSuneetha Ramanujapuram OriginalPaper Article: 74
Regulation of monoamine transporters: Influence of psychostimulants and therapeutic antidepressants Lankupalle D. JayanthiSammanda Ramamoorthy OriginalPaper Article: 73
Patent issues in drug development: Perspectives of a pharmaceutical scientist-attorney Srikumaran Melethil OriginalPaper Article: 72
Kappa opioid antagonists: Past successes and future prospects Matthew D. MetcalfAndrew Coop OriginalPaper Article: 71
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys Michael G. DoddsJennifer E. VisichPaolo Vicini OriginalPaper Article: 70
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques Joshua T. AyersAaron ClausetPeter A. Crooks OriginalPaper Article: 68
Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings Karl G. WagnerRonny Gruetzmann OriginalPaper Article: 67
In vivo microdialysis for PK and PD studies of anticancer drugs Qingyu ZhouJames M. Gallo OriginalPaper Article: 66
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids Roger G. Pertwee OriginalPaper Article: 64
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation Vladimir Piotrovsky OriginalPaper Article: 63
Lung microdialysis—A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review) Markus ZeitlingerMarkus MüllerChristian Joukhadar ReviewPaper Article: 62
k Opioids as potential treatments for stimulant dependence Thomas E. PrisinzanoKevin TidgewellWayne W. Harding OriginalPaper Article: 61
Mu opioid receptor regulation and opiate responsiveness Kirsten M. RaehalLaura M. Bohn OriginalPaper Article: 60
RETRACTED ARTICLE: Recent advances for the treatment of cocaine abuse: Central nervous system immunopharmacotherapy Tobin J. DickersonKim D. Janda OriginalPaper 19 October 2005 Article: 59
RNAi-directed inhibition of DC-SIGN by dendritic cells: Prospects for HIV-1 therapy Madhavan P. N. NairJessica L. ReynoldsDon Sykes OriginalPaper Article: 58
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs Valeria AlconMaria Baca-EstradaMarianna Foldvari OriginalPaper Article: 57
Pharmacokinetics/pharmacodynamics and the stages of drug development: Role of modeling and simulation Jenny Y. ChienStuart FriedrichVikram Sinha OriginalPaper Article: 55
Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling Elizabeth C. M. de LangePaulien G. M. RavenstijnTamara J. van Steeg OriginalPaper Article: 54
A new equivalence based metric for predictive check to qualify mixed-effects models Pravin R. JadhavJogarao V. S. Gobburu OriginalPaper Article: 53
Model-based development of gemcabene, a new lipid-altering agent Jaap W. MandemaDavid HermannDaniel Hartman OriginalPaper Article: 52
Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications Venkatesh A. BhattaramBrian P. BoothJogarao V. S. Gobburu OriginalPaper Article: 51